5-Aryl thiazolidine-2,4-diones as selective PPARγ agonists

5-Aryl thiazolidine-2,4-diones as selective PPARγ agonists 5-Aryl thiazolidine-2,4-diones: discovery of PPAR dual α/γ agonists as antidiabetic agents Aryloxazolidinediones: identification of potent orally active PPAR dual α/γ agonists Thiazolidine-2,4-diones derivatives as PPAR-γ agonists: Synthesis, molecular docking, in vitro and in vivo antidiabetic activity with hepatotoxicity risk evaluation and effect on PPAR-γ gene expression Design, synthesis, in silico molecular docking and biological evaluation of novel oxadiazole based thiazolidine-2,4-diones bis-heterocycles as PPAR-γ agonists Synthesis and biological activities of novel aryl indole-2-carboxylic acid analogs as PPARγ partial agonists Design, Synthesis, and Biological Evaluation of Indole Biphenylcarboxylic Acids as PPARγ Antagonists Benzoxazinones as PPARγ Agonists. 2. SAR of the Amide Substituent and In Vivo Results in a Type 2 Diabetes Model Molecular Design, Synthesis, and Hypoglycemic Activity of a Series of Thiazolidine-2,4-diones Benzoxazinones as PPARγ agonists. part 1: SAR of three aromatic regions